跳至主要内容
临床试验/NCT03827174
NCT03827174终止不适用

Vocational Rehabilitation and Return to Work in Patients With Chronic Pain: a Randomised Controlled Trial

Uppsala University2 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2019年8月14日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
8
试验地点
2
主要终点
Return to work

研究概览

简要总结

This study aims to evaluate whether a vocational behaviour change ability programme has any additional effect on return to work compared with return to work coordination only in persons with chronic pain.

详细描述

New vocational rehabilitation models including the workplace are urgently needed for persons with chronic pain.

Return to work coordination means external and internal coordination regarding sick leave by help of a rehabilitation coordinator from health care. The goal is to establish a common return to work plan between employer and employee as dictated by Swedish law. The hypothesis is that return to work coordination is not sufficient. Additional effects on return to work and work ability from a behaviour change ability programme aiming to enhance work ability by targeting context at the workplace, physical and psychological functioning, and behavioral skills at work are expected.

The hypothesis is tested in a randomised controlled trial. Before the start of the trial a series of 3-6 experimental single case studies will be performed to study the implementation of the interventions more thoroughly.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

盲法说明

The outcomes assessors are blinded to study condition during all measurements. Participants and providers of the return to work coordination intervention are blinded until a rehabilitation plan has been completed. Thereafter allocation to study condition is disclosed and the other components of the behaviour change ability programme are provided to those in the experimental group.

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Chronic pain with a duration for more than 3 months
  • On sick-leave 25%-100% from salaried employment or studies, for at least 30 days
  • Identified employer or director of studies
  • Ability to understand, speak, and write Swedish

排除标准

  • Severe substance use disorder
  • Severe psychiatric illness
  • Recruited participants with employers who does not consent to participate

结局指标

主要结局

Return to work

时间窗: Number of days during a 12-month period from baseline to 12 months post baseline.

Average sick leave according to the Swedish Social Insurance registry, defined as net days.

Work ability

时间窗: 12 months

Self-report. Work Ability Index (WAI). The questionnaire covers 7 dimensions: 1. current work ability compared with lifetime best 2. work ability in relation to the demands of the job 3. number of diagnosed illnesses or limiting conditions 4. estimated impairment owing to diseases/illnesses or limiting conditions 5. amount of sick leave during the last year 6. prognosis of work ability in 2 years' time 7. psychological resources. The dimensions have different scores. A total index is computed ranging from 7 to 49, where higher scores indicate higher work ability.

次要结局

  • Short-term sick leave < 2 weeks, number of days(6 months, 12 months, 24 months)
  • Work Ability(Baseline, 6 months, 24 months)
  • Return to work(Baseline, 6 months, 24 months)
  • Opioid use(Baseline, 6 months, 12 months, 24 months)
  • Pain interference: The Brief Pain Inventory(Baseline, 6 months, 12 months, 24 months)
  • Health-related quality of life: EQ-5D(Baseline, 6 months, 12 months, 24 months)
  • Substance use disorder(Baseline, 6 months, 12 months, 24 months)
  • Pain severity: The Brief Pain Inventory(Baseline, 6 months, 12 months, 24 months)
  • Balance(Baseline, 6 months, 12 months)
  • Functional lifting capacity(Baseline, 6 months, 12 months)
  • Fear of movement and reinjury(Baseline, 6 months, 12 months)
  • Experience of injustice(Baseline, 6 months, 12 months)
  • Physical activity level(Baseline, 6 months, 12 months)
  • Catastrophizing(Baseline, 6 months, 12 months)
  • Depressive symptoms(Baseline, 6 months, 12 months, 24 months)
  • Generalised Anxiety Disorder(Baseline, 6 months, 12 months, 24 months)
  • Grip strength(Baseline, 6 months, 12 months)
  • Psychological inflexibility in pain(Baseline, 6 months, 12 months)
  • Sleep(Baseline, 6 months, 12 months)
  • Global goal achievement(6 months, 12 months, 24 months)
  • Explorative identification of change in biomarkers(Changes from baseline to 6 months.)
  • Cognitive function(Baseline, 6 months, 12 months)

研究者

发起方
Uppsala University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Pernilla Asenlof

Professor

Uppsala University

研究点 (2)

Loading locations...

相似试验